Cicletanine Therapy Is Well Tolerated in Patients with Advanced Pulmonary Arterial Hypertension (PAH)

被引：0
|
作者：
Waxman, A. B. [1 ,2 ]
Lawler, L. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3353
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Patients with pulmonary arterial hypertension related to HIV: Effects of antiretroviral and disease-specific PAH therapy
    Neumann, T.
    Krings, P.
    Reinsch, N.
    Kaelsch, H.
    Konorza, T.
    Esser, S.
    Wachter, R.
    Goehler, A.
    Erbel, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 261 - 261
  • [43] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [44] Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
    Pentikainen, Markku
    Simonen, Piia
    Leskela, Pauliina
    Harju, Terttu
    Jaaskelainen, Pertti
    Asseburg, Christian
    Oksanen, Minna
    Soini, Erkki
    Wennerstrom, Christina
    Puhakka, Airi
    FINPAH Study Grp
    PULMONARY CIRCULATION, 2025, 15 (01)
  • [45] PHYSICAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM A GERMAN CLAIMS DATA ANALYSIS
    Barthuber, L.
    Nill, I
    Jacob, C.
    Schmid, T.
    VALUE IN HEALTH, 2024, 27 (12) : S334 - S334
  • [46] Pulmonary Involvement in Systemic Sclerosis and Pulmonary Arterial Hypertension (PAH)
    Graefenstein, K.
    AKTUELLE RHEUMATOLOGIE, 2011, 36 (01) : 47 - 53
  • [47] Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH)
    Barbera, Joan Albert
    Galie, Nazzareno
    Frost, Adaani
    Ghofrani, Hossein Ardeschir
    Hoeper, Marius
    Mclaughlin, Vallerie
    Peacock, Andrew
    Simonneau, Gerald
    Vachiery, Jean-Luc
    Blair, Christiana
    Miller, Karen
    Harris, Julia
    Langley, Jonathan
    Rubin, Lewis
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [48] Regional Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension (PAH)
    Winkler, T.
    Kohli, P.
    Kelly, V. J.
    Kehl, E. G.
    Kone, M. T.
    Hibbert, K.
    Rodriguez-Lopez, J. M.
    Systrom, D. M.
    Waxman, A. B.
    Venegas, J. G.
    Channick, R. N.
    Harris, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [49] Combination therapy in patients with pulmonary arterial hypertension
    Ewert, R.
    Opitz, C. F.
    Schaeper, C.
    Glaeser, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (40) : S187 - S190
  • [50] One year experience with intravenous treprostinil in pulmonary arterial hypertension (PAH) patients
    McLaughlin, VV
    Barst, R
    Gomberg-Maitland, M
    Tapson, V
    Krichman, A
    Widlitz, A
    Rich, S
    Benza, R
    CHEST, 2005, 128 (04) : 160S - 160S
12345